ANNUAL REPORT FOR THE FINANCIAL YEAR 2024-25
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sunil Healthcare Ltd has submitted its Annual Report for the financial year 2024-25 to BSE and Calcutta Stock Exchange, as required under SEBI LODR Regulation 34(1). The 51st Annual General Meeting is scheduled for Monday, September 29, 2025, at 12:30 PM IST, to be held via Video Conferencing (VC)/OAVM. Key business items include adoption of audited financial statements (standalone and consolidated), re-appointment of Mr. Krishna Venkatachalam Rajan as Non-Executive Director (retiring by rotation), and appointment of M/s ATCS & Associates as Secretarial Auditor for a five-year term from FY 2025-26 to FY 2029-30. The company has not declared any dividend since 2008-09. Statutory auditors remain Singhi & Co., and the report is available on the company's website.
Routine regulatory filing with no immediate material impact on shareholders. Investors should review the full annual report for detailed financial performance, auditor's opinion, and any flagged concerns. The five-year secretarial auditor appointment is a procedural compliance requirement under amended SEBI LODR norms.